Search research articles
Contact Us
Filters
Showing results (71-80 of 167) with videos related to
Page
of 17
Sort By:
Renal Failure
|
May 9, 1998
Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate
G Tramonti, M Ferdeghini, C Donadio, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
July 1, 1989
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma
A Gadducci, M Ferdeghini, T Bartolini, et al.
Oncology Reports
|
May 20, 2011
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer
A Gadducci, M Ferdeghini, A Fanucchi, et al.
The Journal of Clinical Investigation
|
August 1, 1987
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin
R Bianchi, G Iervasi, A Pilo, et al.
Informatics for Health & Social Care
|
August 19, 2011
Telematic integration of health data: a practicable contribution
Lorenzo Guerriero, Ezio M Ferdeghini, Silvia R Viola, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology
A Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma
A Gadducci, M Ferdeghini, T Ceccarini, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
July 1, 1989
External quality control survey for alpha-fetoprotein assay
G C Zucchelli, A Pilo, M Ferdeghini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
S Ricci, A Antonuzzo, L Galli, et al.
The American Journal of Medicine
|
October 20, 1999
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects
F Carmassi, M Morale, L Ferrini, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 167) with videos related to
Sort By:
Page
of 17
Renal Failure
|
May 9, 1998
Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate
G Tramonti, M Ferdeghini, C Donadio, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
July 1, 1989
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma
A Gadducci, M Ferdeghini, T Bartolini, et al.
Oncology Reports
|
May 20, 2011
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer
A Gadducci, M Ferdeghini, A Fanucchi, et al.
The Journal of Clinical Investigation
|
August 1, 1987
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin
R Bianchi, G Iervasi, A Pilo, et al.
Informatics for Health & Social Care
|
August 19, 2011
Telematic integration of health data: a practicable contribution
Lorenzo Guerriero, Ezio M Ferdeghini, Silvia R Viola, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology
A Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma
A Gadducci, M Ferdeghini, T Ceccarini, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
July 1, 1989
External quality control survey for alpha-fetoprotein assay
G C Zucchelli, A Pilo, M Ferdeghini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
S Ricci, A Antonuzzo, L Galli, et al.
The American Journal of Medicine
|
October 20, 1999
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects
F Carmassi, M Morale, L Ferrini, et al.
Page
of 17